Morgan Stanley Keeps Globe Life at Equal-Weight, Raises PT to $127
ByAinvest
Monday, Jul 14, 2025 10:08 am ET1min read
FISI--
In the past few weeks, several key analysts have revised their ratings and price targets for Globe Life. JPMorgan Chase & Co. raised its price target to $160, while Wells Fargo & Company reduced its target to $139. Wall Street Zen upgraded Globe Life to a "buy" rating, and Piper Sandler lowered its target to $147. Despite these changes, Morgan Stanley's decision to keep the stock at "equal weight" reflects a more cautious stance compared to the bullish ratings from other firms.
Globe Life's recent earnings report, released on April 30th, showed earnings per share of $3.07, missing the consensus estimate of $3.24. However, the company reported a 4.5% increase in revenue year-over-year, reaching $1.48 billion. The firm also declared a quarterly dividend of $0.27 per share, with an annualized payout of $1.08 and a dividend yield of 0.91%.
The company's financial health is indicated by a quick ratio of 0.07, a current ratio of 0.07, and a debt-to-equity ratio of 0.43. Its market capitalization stands at $9.76 billion, with a P/E ratio of 9.62 and a beta of 0.56. The business's 50-day moving average price is $120.95, and its 200-day moving average price is $121.16.
Institutional investors have shown interest in Globe Life, with 81.61% of the stock owned by institutions. Insider activity includes CEO Frank M. Svoboda selling 6,019 shares on May 20th, representing a 16.13% decrease in his ownership. The average rating among analysts is "Moderate Buy," with a price target of $139.55.
The recent changes in analyst ratings and price targets for Globe Life reflect a mix of optimism and caution. While several firms have raised their targets, Morgan Stanley's decision to maintain an "equal weight" rating suggests a more balanced view of the stock's potential. Investors should consider these updates when evaluating Globe Life's prospects.
References:
[1] https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-increases-globe-life-nysegl-price-target-to-16000-2025-07-08/
GL--
JPM--
MS--
PIPR--
Morgan Stanley Keeps Globe Life at Equal-Weight, Raises PT to $127
On Monday, July 1st, Morgan Stanley increased its price target for Globe Life (NYSE:GL) to $127, maintaining its "equal weight" rating on the stock. This adjustment comes after a series of recent changes in analyst ratings and price targets from other major financial institutions. Morgan Stanley's move follows a pattern of increased optimism among analysts regarding Globe Life's potential.In the past few weeks, several key analysts have revised their ratings and price targets for Globe Life. JPMorgan Chase & Co. raised its price target to $160, while Wells Fargo & Company reduced its target to $139. Wall Street Zen upgraded Globe Life to a "buy" rating, and Piper Sandler lowered its target to $147. Despite these changes, Morgan Stanley's decision to keep the stock at "equal weight" reflects a more cautious stance compared to the bullish ratings from other firms.
Globe Life's recent earnings report, released on April 30th, showed earnings per share of $3.07, missing the consensus estimate of $3.24. However, the company reported a 4.5% increase in revenue year-over-year, reaching $1.48 billion. The firm also declared a quarterly dividend of $0.27 per share, with an annualized payout of $1.08 and a dividend yield of 0.91%.
The company's financial health is indicated by a quick ratio of 0.07, a current ratio of 0.07, and a debt-to-equity ratio of 0.43. Its market capitalization stands at $9.76 billion, with a P/E ratio of 9.62 and a beta of 0.56. The business's 50-day moving average price is $120.95, and its 200-day moving average price is $121.16.
Institutional investors have shown interest in Globe Life, with 81.61% of the stock owned by institutions. Insider activity includes CEO Frank M. Svoboda selling 6,019 shares on May 20th, representing a 16.13% decrease in his ownership. The average rating among analysts is "Moderate Buy," with a price target of $139.55.
The recent changes in analyst ratings and price targets for Globe Life reflect a mix of optimism and caution. While several firms have raised their targets, Morgan Stanley's decision to maintain an "equal weight" rating suggests a more balanced view of the stock's potential. Investors should consider these updates when evaluating Globe Life's prospects.
References:
[1] https://www.marketbeat.com/instant-alerts/jpmorgan-chase-co-increases-globe-life-nysegl-price-target-to-16000-2025-07-08/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet